TN2011000092A1 - Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide - Google Patents

Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide

Info

Publication number
TN2011000092A1
TN2011000092A1 TN2011000092A TN2011000092A TN2011000092A1 TN 2011000092 A1 TN2011000092 A1 TN 2011000092A1 TN 2011000092 A TN2011000092 A TN 2011000092A TN 2011000092 A TN2011000092 A TN 2011000092A TN 2011000092 A1 TN2011000092 A1 TN 2011000092A1
Authority
TN
Tunisia
Prior art keywords
dimethylmorpholin
trifluoromethoxy
carboxamide
biphenyl
cis
Prior art date
Application number
TN2011000092A
Other languages
French (fr)
Inventor
La Cruz Marliyn De
Stephanie Kay Dodd
Liladhar Murlidhar Waykole
Raeann Wu
Joginder Singh Bajwa
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/056918 external-priority patent/WO2010033481A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2011000092A1 publication Critical patent/TN2011000092A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Salts of N-[6-(cis-2,6-dimethylmorpholin-4-y)pyridine-3-yl]-2-methyl-4'- (trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide are prepared and characterized.
TN2011000092A 2009-09-15 2011-02-24 Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide TN2011000092A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/056918 WO2010033481A1 (en) 2008-09-17 2009-09-15 Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide

Publications (1)

Publication Number Publication Date
TN2011000092A1 true TN2011000092A1 (en) 2012-09-05

Family

ID=55024391

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000092A TN2011000092A1 (en) 2009-09-15 2011-02-24 Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide

Country Status (1)

Country Link
TN (1) TN2011000092A1 (en)

Similar Documents

Publication Publication Date Title
TN2011000673A1 (en) Bace inhibitors
UA102251C2 (en) Aminidihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
NZ606589A (en) 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof
MX2013002597A (en) Pesticidal arylpyrrolidines.
PH12014501273A1 (en) Intranasal dexmedetomidine compositions and methods of use thereof
MX2013005356A (en) Use of fluopyram for controlling nematodes in crops and for increasing yield.
MY166789A (en) Arginine salts and their uses for the treatment of illnesses in the oral cavity
UA104885C2 (en) Isothiazolyloxyphenyl amidines and use thereof as fungicides
JO2889B1 (en) Salts of N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4’-(trifluoromethoxy)[1,1’-biphenyl]-3-carboxamide
IL229113A0 (en) Derivatives of n -[(1h-pyrazol-1-yl)aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
TN2010000299A1 (en) Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropy-ran-4-yl)-propionamide
MX342947B (en) Treatment of type 2 diabetes.
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
PL2462121T3 (en) Derivatives of 2h pyridazin-3-ones, their preparation and their use as scd-1 inhibitors
IL230484A (en) 6-(n-(7-chloro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-n-methylbenzofuran-3-carboxamide and pharmaceutical composition comprising it
MX2012010127A (en) Derivatives of aminoindanes, their preparation and their application in therapeutics.
IL215103A0 (en) N-[(6-AZA-bicyclo[3.2.1]OCT-5-YL]-ARYL-METHYL]-HETEROBENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE OF SAME
IL214408A0 (en) Derivatives of 6-(6-substituted-triazolopyidazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
IN2012DN05142A (en)
AP2013006816A0 (en) Ptocess for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation
TN2011000092A1 (en) Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
MX2011011180A (en) Compounds having a physiological effect.
ZA201204339B (en) Novel (heterocycle-tetrahydropyridine)(piperazinyl)-1-alcanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alcanone derivatives,and use thereof as p75 inhibitors
TH0901004168A (en) Salt of N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'- (Trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
IL215673A0 (en) Derivatives of n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof